 TEL AVIV, Israel and BETHESDA, Md., May 11, 2021 PRNewswire -- Cannabics Pharmaceuticals Inc. OTCQB: CNBX, a global leader in the development of cancer related cannabinoid-based medicine, announced today that it had filed a patent application under the Patent Cooperation Treaty PCT for novel formulations developed for treatment of various cancer types. 